Similar to patients without IBD, those with IBD are at similar risk for sporadic cancers and age-appropriate screening guidelines should be followed. Patients with IBD are at an increased risk of cancer from long-standing intestinal inflammation and/or the use of immunosuppressive therapies to treat IBD. As the population of patients with IBD ages, there is an increasing risk of cancer development. Many of these patients will require cancer treatment and many will require further treatment for their IBD. Much remains unknown regarding the interaction between IBD, IBD medications, and cancer treatment, and the risk of cancer recurrence in patients with IBD and a personal history of cancer. It is hoped that with further research and real-world experience, cancer risks in patients with IBD will be further elucidated as they relate to specific cancer types and specific drugs used to treat IBD.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.